Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss

Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss

Authors

  • Rachel C Hill Weill Cornell Medical College, New York, NY
  • Yu Wang Wake Forest School of Medicine, Department of Dermatology, Wake Forest, NC
  • Bilal Shaikh Weill Cornell Medicine, Division of Biostatistics, Department of Population Health Sciences, New York, NY
  • Michael M. Ong Weill Cornell Medical College, New York, NY
  • Paul J. Christos Weill Cornell Medicine, Division of Biostatistics, Department of Population Health Sciences, New York, NY
  • Shari R. Lipner Weill Cornell Medicine, Department of Dermatology, New York, NY

Keywords:

spironolactone, hypotension, blood pressure monitoring, alopecia, androgenetic aloecia

References

Desai D, Nohria A, Sikora M, et al. Examining blood pressure changes with spironolactone for alopecia: A retrospective analysis. J Am Acad Dermatol. Published online August 27, 2024. doi:10.1016/j.jaad.2024.07.1523

Hill RC, Wang Y, Shaikh B, Ong M, Christos PJ, Lipner SR. Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study. J Am Acad Dermatol. 2024;90(6):1245-1247. doi:10.1016/j.jaad.2024.01.057

Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. doi:10.1111/j.1365-2133.2005.06218.x

Burns LJ, De Souza B, Flynn E, Hagigeorges D, Senna MM. Spironolactone for treatment of female pattern hair loss. J Am Acad Dermatol. 2020;83(1):276-278. doi:10.1016/j.jaad.2020.03.087

James JF, Jamerson TA, Aguh C. Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. J Am Acad Dermatol. 2022;86(2):425-429. doi:10.1016/j.jaad.2021.07.048

Downloads

Published

2025-07-31

How to Cite

1.
Hill RC, Wang Y, Shaikh B, Ong MM, Christos PJ, Lipner SR. Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss. Dermatol Pract Concept. 2025;15(3):5337. doi:10.5826/dpc.1503a5337

Share